Senior insider sale
Chief Scientific Officer at CONTINEUM THERAPEUTICS, INC. — senior position signals high conviction
$154.5K
12.51K shares
What this filing means
LORRAIN DANIEL S. plans to sell 12.51K shares of CONTINEUM THERAPEUTICS, INC. valued at approximately $154.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/3/2026ACC: 0001950047-26-000891
Officer· Chief Scientific Officer
Since Mar 2026
12.51K
Shares to sell
$154.5K
Approx. market value
4.17K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
5/9/2017
4.17KTotal acquired4.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/9/2017 | Restricted Stock Units N/A | 4.17K | — |
| Total | 4.17K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
4.17K
Market value
$43.5K
1/5/2026
—Completed
Units to sell
4.17K
Market value
$51.0K
12/23/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.17K
Market value
$60.0K
2/3/2026
Total
Units
12.51K
Value
$154.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/5/2026 | 4.17K | $43.5K | — | Completed |
12/23/2025 | 4.17K | $51.0K | — | Completed |
| Planned — Approximate Date | ||||
2/3/2026 | 4.17K | $60.0K | NASDAQ | Planned |
| Total | 12.51K | $154.5K | ||